Horizon Technology Finance (NASDAQ:HRZN) (NASDAQ: HRZN) is a publicly traded business development company (BDC) that provides debt and equity financing solutions to venture growth‐stage companies in the technology, life sciences and cleantech sectors. By focusing on high‐potential enterprises that are beyond the start‐up phase but may not yet have access to traditional bank financing or public markets, Horizon offers customized capital structures such as senior secured loans, second‐lien debt, convertible notes and equity co‐investments. Its flexible financing approach is designed to support companies through critical periods of growth, product development and market expansion.
Headquartered in Irvine, California, Horizon Technology Finance primarily serves U.S.‐based companies, although it will consider select opportunities in Canada and Europe when they align with its investment criteria. The company’s investment team conducts thorough due diligence, leveraging sector expertise to evaluate technology platforms, clinical progress or regulatory pathways, and market potential. Through its relationships with venture capital firms and strategic partners, Horizon often participates alongside leading investors, providing additional debt capital or structured equity to complement existing funding rounds.
Since its incorporation in 2006, Horizon Technology Finance has navigated multiple economic and industry cycles, enabling it to refine its credit underwriting and portfolio management disciplines. Over the years, the company has developed a track record of supporting more than one hundred portfolio companies, with investments spanning software, hardware, life sciences, healthcare services and renewable energy technologies. Its public listing on Nasdaq in 2014 broadened investor access to the rapidly growing segment of venture debt, positioning Horizon as one of the few BDCs dedicated exclusively to technology‐driven ventures.
Horizon’s leadership team combines experience in venture capital, investment banking and corporate finance. Its board and management group are led by professionals who have previously held senior roles at top-tier investment firms, technology companies and regulatory bodies. This seasoned governance structure emphasizes a disciplined approach to risk management, rigorous portfolio monitoring and active engagement with portfolio company management. By aligning its interests with shareholders through co‐investment and performance‐based incentive structures, Horizon seeks to deliver attractive risk‐adjusted returns while supporting the next generation of high‐growth technology and life sciences innovators.
